Clinical trials in Alzheimers disease Alzheimers disease is where the 2025 data forced the largest revision, and where the contrast between observational promise and trial outcome is sharpest
I recently returned from the largest peptide conference in the US, and let me tell you, the conversations shifted from this is miraculous, everyone should get it to it works for many under the right protocol. So lets unpack what GHK-Cu is, what it does, and where it might belong in a responsible, biology-informed healthspan strategy
Be cautious of black-market sources or underground sellers
Furthermore, alcohol can impair judgment and decision-making, potentially leading to medication non-adherence or unsafe behaviors
[1] Many patients who have had their gallbladder removed can proceed with Wegovy therapy under appropriate medical supervision, though individual circumstances must be carefully assessed by a prescribing clinician
However, this deadline could be extended, pending the outcome of ongoing court cases